Fri, 06 Nov 2026
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025